Carregant...

Repurposing ribosome-targeting antibiotics to overcome resistance to venetoclax in acute myeloid leukemia

Venetoclax, a selective B-cell lymphoma 2 inhibitor, has shown promise in the treatment of acute myeloid leukemia. However, the development of drug resistance limits its clinical efficacy. In our study, we discovered that ribosome-targeting antibiotics can be repurposed to overcome venetoclax resist...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cell Oncol
Autors principals: Sharon, David, Chan, Steven M.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7051130/
https://ncbi.nlm.nih.gov/pubmed/32158926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1712182
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!